ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717696 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717696; 2) Community: the network communities that were significantly associated with the response to NSC 717696; 3) Molecule: the relationships between components within communities and NSC 717696; 4) MDR: the compounds that were significantly associated with the NSC 717696.

NSC Compound Enrichment Correlation
NSC 633497 Null 0.0406225271888776 0.23175571
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0406225271888776 -0.16329337
NSC 638487 (Z) 4-Acetoxy-(3,4',5)-trimethoxystilbene 0.0406225271888776 0.052139862
NSC 648365 Insulin-Methotrexate conjugate 0.0406225271888776 -0.077864106
NSC 649677 Null 0.0406225271888776 0.063751348
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0406225271888776 0.084759823
NSC 657751 Null 0.0406225271888776 0.067622417
NSC 658093 Null 0.0406225271888776 -0.036728526
NSC 658114 Null 0.0406225271888776 -0.056012562
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0406225271888776 0.037424451
Total:50  Current:41    [First] [Prev] [Next] [Last]